Back
Greif, Inc. Vs. Rigel Pharmaceuticals, Inc. Industry Stock Comparison
Buy
54
GEF
Greif, Inc.
Last Price:
$68.68
Seasonality Move:
-1.22%
Buy
72
RIGL
Rigel Pharmaceuticals, Inc.
Last Price:
$41.63
Seasonality Move:
-1.35%
Buy
54
Greif, Inc. (GEF)
is a Buy
Is Greif, Inc. a Buy, Sell or Hold?
-
The current Greif, Inc. [GEF] share price is $70.31. The Score for GEF is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
GEF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
72
Rigel Pharmaceuticals, Inc. (RIGL)
is a Buy
Is Rigel Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rigel Pharmaceuticals, Inc. [RIGL] share price is $41.77. The Score for RIGL is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
RIGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GEF Stock Price Chart
What is Greif, Inc.'s stock price today?
-
The Greif, Inc. share price today is $70.31The current trend is moderately bullish and GEF is experiencing slight buying pressure.
RIGL Stock Price Chart
What is Rigel Pharmaceuticals, Inc.'s stock price today?
-
The Rigel Pharmaceuticals, Inc. share price today is $41.77Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RIGL is experiencing selling pressure, which indicates risk of future bearish movement.
GEF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.32 | Buy |
| Relative Strength Index (14 RSI): | 74.3 | Buy |
| Chaikin Money Flow: | 115137 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (62.02 - 68.18) | Buy |
| Bollinger Bands (100): | (58.8 - 66.12) | Buy |
RIGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.92 | Buy |
| Relative Strength Index (14 RSI): | 48.84 | Sell |
| Chaikin Money Flow: | -387889 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.3 - 48) | Sell |
| Bollinger Bands (100): | (28.82 - 43.02) | Buy |
GEF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 68.47 | Buy |
| 20-day SMA: | 66.15 | Buy |
| 50-day SMA: | 61.86 | Buy |
| 200-day SMA: | 60.58 | Buy |
| 8-day EMA: | 68.71 | Buy |
| 20-day EMA: | 66.37 | Buy |
| 50-day EMA: | 63.69 | Buy |
| 200-day EMA: | 61.98 | Buy |
RIGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.82 | Sell |
| 20-day SMA: | 45.2 | Sell |
| 50-day SMA: | 37.87 | Buy |
| 200-day SMA: | 27.55 | Buy |
| 8-day EMA: | 16.53 | Buy |
| 20-day EMA: | 7.59 | Buy |
| 50-day EMA: | 3.22 | Buy |
| 200-day EMA: | 0.83 | Buy |
Greif, Inc. Earnings Growth & GEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.00 per share, and an increase next year of $1.18 per share.
Rigel Pharmaceuticals, Inc. Earnings Growth & RIGL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.13 per share, and a decrease next year of $2.31 per share.
Greif, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rigel Pharmaceuticals, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||